4
Changes in Ownership
Spero Therapeutics, Inc. Filed Acc 0000950170-25-112661
Director sold 6,572 shares at $1.97 ($12,947)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mahadevia Ankit Director | 2025-08-28 | Sale | −6,572 | $1.97 | $12,947 | 703,294 | D |
| Open-market sales · 6,572 sh · avg $1.97 · $12,947 | |||||||
Loading xslF345X05/ownership.xml…